Peter Allen
Président chez BENEVOLENTAI
Fortune : 413 319 $ au 30/06/2024
Profil
Peter Vance Allen est un homme d'affaires britannique qui a été à la tête de 11 entreprises différentes. Actuellement, M. Allen occupe le poste de président non exécutif d'Abcam Plc, de président non exécutif d'Oxford Nanopore Technologies Ltd, de président non exécutif d'Advanced Medical Solutions Group Plc et de président non exécutif indépendant de Clinigen Group Plc. Peter Vance Allen est également membre du conseil d'administration de la St Marys School Clane et d'Istesso Ltd. Il a précédemment occupé le poste de président non exécutif indépendant de Future Plc, de président de Chroma Therapeutics Ltd, de président non exécutif de Diurnal Group plc et de président de Diurnal Ltd. (une filiale de Diurnal Group plc), contrôleur financier de British Ports Holdings Plc, président non exécutif et directeur général de Proximagen Group Plc, président non exécutif de Kyowa Kirin International Plc, président non exécutif de Kyowa Kirin Ltd, directeur financier et directeur général adjoint de Celltech Group Plc, directeur financier d'Abacus Group Ltd, contrôleur financier d'Associated British Ports Holdings Plc et contrôleur financier de L'Oréal (UK) Ltd.
Détentions connues dans des sociétés publiques
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
ABCAM PLC
0,01% | 15/02/2023 | 18 563 ( 0,01% ) | 278 060 $ | 31/12/2022 |
| 31/12/2023 | 50 000 ( 0,02% ) | 135 259 $ | 30/06/2024 |
Postes actifs de Peter Allen
| Sociétés | Poste | Début |
|---|---|---|
| BENEVOLENTAI | Président | 02/05/2024 |
Istesso Ltd.
 Istesso Ltd. BiotechnologyHealth Technology Istesso Ltd. Operates as a drug discovery and development company. The company was founded in 2017 and is headquartered in London, the United Kingdom. | Directeur/Membre du Conseil | - |
| St Marys School Clane | Directeur/Membre du Conseil | - |
Anciens postes connus de Peter Allen
| Sociétés | Poste | Fin |
|---|---|---|
| ADVANCED MEDICAL SOLUTIONS GROUP PLC | Président | 01/01/2024 |
| OXFORD NANOPORE TECHNOLOGIES PLC | Président | 31/07/2022 |
| CLINIGEN GROUP PLC | Président | 01/09/2021 |
Diurnal Ltd.
 Diurnal Ltd. Pharmaceuticals: MajorHealth Technology Part of Neurocrine Biosciences, Inc., Diurnal Ltd. is a European, British UK-headquartered specialty pharmaceutical company founded in 2004. The company is based in Cardiff, UK. The company is dedicated to developing lifelong treatments for rare and chronic endocrine conditions. | Président | 31/12/2020 |
| DIUL GROUP | Président | 30/06/2020 |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 6 |
|---|---|
| OXFORD NANOPORE TECHNOLOGIES PLC | Electronic Technology |
| FUTURE PLC | Consumer Services |
| SCANCELL HOLDINGS PLC | Health Technology |
| ADVANCED MEDICAL SOLUTIONS GROUP PLC | Health Technology |
| ABCAM PLC | Health Technology |
| BENEVOLENTAI | Health Technology |
| Entreprise privées | 20 |
|---|---|
Chroma Therapeutics Ltd.
 Chroma Therapeutics Ltd. BiotechnologyHealth Technology Chroma Therapeutics Ltd. engages in the discovery and development of therapies for the treatment of cancer and inflammation. It focuses on the discovery and development of novel small molecule drugs based upon chromatin biology and novel cell accumulation approaches. The firm uses chromatin biology, drug accumulation approaches to discover and develop cancer, inflammation treatments and small molecule drugs. The company was founded by David Allis, Alan Hornsby Davidson, Alan Hastings Drummond, Anthony Kouzarides and Paul Workman in September 2001 and is headquartered in Abingdon, the United Kingdom. | Health Technology |
Inion Oy
 Inion Oy BiotechnologyHealth Technology Inion Oy is a medical devices company focused on the development and commercialization of innovative biodegradable and bioactive implants for applications in Spine and Specialty Orthopedics applications. By targeting key strategic markets in the USA and select territories in the rest of the world, Inion has built a product portfolio sold through a dedicated network of specialist distributors. Inion's products include biodegradable plates, screws, pins and membranes, which are used to enhance the healing of bone or soft tissue injuries, such as those caused by trauma or by reconstructive surgery. Inion's core expertise is in the design and manufacture of implants from its proprietary Inion Optima™ family of biomaterials, which enables the Company to develop medical implants with properties tailored for specific surgical applications, in terms of strength, flexibility and rate of degradation. Incorporated in 2000, Inion has offices in the UK and USA, and its head office, R&D and manufacturing facilities are in Tampere, Finland. | Health Technology |
Abacus Group Ltd.
 Abacus Group Ltd. Electronics DistributorsDistribution Services Abacus Group Ltd. distributes connector, passive, electromechanical, power supply and battery products. It also provides contract manufacturing services which helps in making electronic equipment such as display peripherals. The company was founded in 1972 and is headquartered in Stevenage, the United Kingdom. | Distribution Services |
Kyowa Kirin International Plc
 Kyowa Kirin International Plc Pharmaceuticals: MajorHealth Technology Kyowa Kirin International Plc is a specialty pharmaceutical company, which engages in the development and commercialization of prescription medicines for the treatment of unmet therapeutic needs in major markets. It offers Sancuso, a prescription medicine used to prevent nausea and vomiting in people receiving some types of chemotherapy treatment and Abstral, a medicine used in the management of breakthrough pain in adult patients using opioid therapy for chronic cancer pain. The company was founded in 1995 and is headquartered in Galashiels, the United Kingdom. | Health Technology |
| British Ports Holdings Plc | |
Acambis Plc
 Acambis Plc BiotechnologyHealth Technology Acambis Plc develops biopharmaceutical products and vaccines. It offers ACAM2000, a smallpox vaccine for emergency-use stockpiling; and ChimeriVax-JE, a single-dose Japanese encephalitis vaccine for endemic markets and travelers. Its products in pipeline include ChimeriVax-JE, ChimeriVax-West Nile, and ChimeriVax-Dengue. The company was founded in 1992 and is headquartered in Cambridge, UK. | Health Technology |
Proximagen Group Plc
 Proximagen Group Plc Miscellaneous Commercial ServicesCommercial Services Proximagen Group Plc engages in the business of discovery and development of therapeutic treatments. The company was founded by Jenner Peter on November 2003 and is headquartered in Cambridge, the United Kingdom. | Commercial Services |
Celltech Group Plc
 Celltech Group Plc BiotechnologyHealth Technology Celltech Group Plc was one of the leading European biotechnology company which is engaged in discovery and development of innovative drugs. The company was located in Slough, United Kingdom. | Health Technology |
| Associated British Ports Holdings Plc /Cardiff Bay Estates/ | Finance |
L'Oréal (UK) Ltd.
 L'Oréal (UK) Ltd. Wholesale DistributorsDistribution Services L'Oréal (UK) Ltd. produces cosmetics and perfumes. It has various brands in professional products, consumer products, luxury products, active cosmetics and the body shop. The company was founded in 1907 by Eugne Schueller and is located in London, UK. | Distribution Services |
TMO Renewables Ltd.
 TMO Renewables Ltd. BiotechnologyHealth Technology TMO Renewables Ltd. provides biological technology services. It is a unique high-temperature bio-ethanol process boasts high efficiencies and fast conversion rates. The company capable includes utilizing all of the sugars, such as complex longer-chain forms. The firm has built cellulosic ethanol process demonstration unit, which integrates all the necessary steps in a continuous ethanol production process. TMO Renewables was founded in 2002 and is headquartered in Guildford, the United Kingdom. | Health Technology |
Clinigen Ltd.
 Clinigen Ltd. Miscellaneous Commercial ServicesCommercial Services Clinigen Ltd. engages in the provision of pharmaceutical products and services. It operates through the following segments: Commercial Medicines, Unlicensed Medicines, and Clinical Trial Services. The Commercial Medicines segment acquires rights to niche hospital-only and critical care products and also provides access to licensed and branded generic. The Unlicensed Medicines segment supplies unlicensed medicines to hospital pharmacists and physicians for patients with a high unmet medical need. The Clinical Trial Services offers comparator medicines and services to clinical trials and IITs. The company was founded by Andrew Leaver in June 2010 and is headquartered in Burton-on-Trent, the United Kingdom. | Commercial Services |
Kyowa Kirin Ltd.
 Kyowa Kirin Ltd. Pharmaceuticals: MajorHealth Technology Founded in 1998, Kyowa Kirin Ltd. is a British pharmaceutical company that develops, manufactures, and distributes pharmaceutical products. Part of Kirin Holdings Co., Ltd., the company is based in London, UK. | Health Technology |
Mecom Group Ltd.
 Mecom Group Ltd. Publishing: NewspapersConsumer Services Mecom Group Ltd. engages in publishing newspaper, consumer business activities, and content in Europe. The company publishes various newspapers such as regional daily newspapers, free door-to-door newspapers, and magazines. It substantial operates newspaper websites and standalone niche websites, hyper-local websites, printing plants for printing publications, paid-for dailies, and free-sheet titles in the Netherlands. Mecom Group was founded by David John Montgomery in 2000 and is headquartered in London, the United Kingdom. | Consumer Services |
Macrotarg Ltd.
 Macrotarg Ltd. BiotechnologyHealth Technology Macrotarg Ltd. is a biotechnology research and British experimental development company founded in 2007. The private company is based in Winnersh, UK. | Health Technology |
| St. Mary's School (Calne) Services Ltd. | |
BBI Diagnostics Group 2 Plc
 BBI Diagnostics Group 2 Plc Medical/Nursing ServicesHealth Services BBI Diagnostics Group 2 Plc provides diagnostic tests and materials. It offers a portfolio of products and services that are provided to the diagnostic, healthcare, research, defense, and food industries. The company was founded on October 22, 2013 and is headquartered in Bedford, the United Kingdom. | Health Services |
Diurnal Group Ltd.
 Diurnal Group Ltd. Pharmaceuticals: MajorHealth Technology Diurnal Group plc engages in the development of products for the life-long treatment of chronic endocrine conditions, including congenital adrenal hyperplasia and adrenal insufficiency. It focuses on circadian-based endocrinology to yield novel product candidates in the rare and chronic endocrine disease arena. The company was founded by Richard John Martin Ross in 2004 and is headquartered in Cardiff, the United Kingdom. | Health Technology |
Diurnal Ltd.
Diurnal Ltd. Pharmaceuticals: MajorHealth Technology Part of Neurocrine Biosciences, Inc., Diurnal Ltd. is a European, British UK-headquartered specialty pharmaceutical company founded in 2004. The company is based in Cardiff, UK. The company is dedicated to developing lifelong treatments for rare and chronic endocrine conditions. | Health Technology |
Istesso Ltd.
Istesso Ltd. BiotechnologyHealth Technology Istesso Ltd. Operates as a drug discovery and development company. The company was founded in 2017 and is headquartered in London, the United Kingdom. | Health Technology |
